Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics

Square2 Systems

Status: Enrolling

Conditions: Substance Use Disorders (SUDs)

Treatments: Other: Cogito digital therapeutics development platform

Study type: Observational

Funder types: Industry; NIH

Identifiers

NCT07104396

1R43DA060729-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This is a research study to evaluate the usability of the Cogito digital therapeutics development platform.

The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population.

And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).

Full description

Each participant will be asked to:

• Complete an interactive tutorial describing what Cogito is and how to create a sample guide, sample activities, and a sample survey.
• Explore using the various Cogito processes by completing a "functionality scavenger hunt". In this scavenger hunt, participants will be walked through a series of activities to create new guides, activities and surveys.
• Complete surveys to provide feedback on participants' experience using Cogito

Enrollment: 20 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• At least 18 years
• PhD and/or MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher.
• Training or trained in substance use disorder (SUDs) research.
• Must state a specific interest in digital therapeutics for SUDs.

Exclusion criteria

• Those who do not meet inclusion criteria.